171 related articles for article (PubMed ID: 7286580)
1. Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity.
O'Keefe SJ; Abraham R; El-Zayadi A; Marshall W; Davis M; Williams R
Gastroenterology; 1981 Dec; 81(6):1017-24. PubMed ID: 7286580
[No Abstract] [Full Text] [Related]
2. Protein turnover in acute and chronic liver disease.
O'Keefe SJ; Abraham RR; Davis M; Williams R
Acta Chir Scand Suppl; 1981; 507():91-101. PubMed ID: 6797209
[TBL] [Abstract][Full Text] [Related]
3. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
Ahmed N; Thornalley PJ; Lüthen R; Häussinger D; Sebekova K; Schinzel R; Voelker W; Heidland A
J Hepatol; 2004 Dec; 41(6):913-9. PubMed ID: 15582123
[TBL] [Abstract][Full Text] [Related]
4. Liver disease and nutrition.
Mezey E
Gastroenterology; 1978 Apr; 74(4):770-83. PubMed ID: 344129
[TBL] [Abstract][Full Text] [Related]
5. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion.
McCullough AJ; Mullen KD; Kalhan SC
Hepatology; 1998 Nov; 28(5):1357-64. PubMed ID: 9794922
[TBL] [Abstract][Full Text] [Related]
6. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
[TBL] [Abstract][Full Text] [Related]
7. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
[TBL] [Abstract][Full Text] [Related]
8. A rapid method for monitoring serum neutral amino acid concentrations in severe liver disease.
Watanabe A; Higashi T; Nagashima H
Hepatogastroenterology; 1981 Feb; 28(1):17-9. PubMed ID: 6260614
[TBL] [Abstract][Full Text] [Related]
9. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Hamberg O; Vilstrup H
Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII expression in liver disease.
Hollestelle MJ; Geertzen HG; Straatsburg IH; van Gulik TM; van Mourik JA
Thromb Haemost; 2004 Feb; 91(2):267-75. PubMed ID: 14961153
[TBL] [Abstract][Full Text] [Related]
12. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
[TBL] [Abstract][Full Text] [Related]
13. Metabolic buffers in hepatic failure.
Grossi CE; Prytz B; Rousselot LM
Surgery; 1968 Nov; 64(5):928-33. PubMed ID: 5687843
[No Abstract] [Full Text] [Related]
14. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation.
Tietge UJ; Bahr MJ; Manns MP; Böker KH
Transpl Int; 2003 Jan; 16(1):1-8. PubMed ID: 12545334
[TBL] [Abstract][Full Text] [Related]
15. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
[TBL] [Abstract][Full Text] [Related]
16. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
18. [Hepatic biotransformation and conjugation of dehydrocholic acid in patients with cirrhosis (author's transl)].
Poupon RY; Raizman A; Brumault JC; Infante R; Darnis F
Gastroenterol Clin Biol; 1979 Dec; 3(12):879-84. PubMed ID: 535692
[No Abstract] [Full Text] [Related]
19. [Amino acid disturbances in liver failure].
Fischer JF
Ann Anesthesiol Fr; 1977; 18(12):966-74. PubMed ID: 24395
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
Tietge UJ; Böker KH; Manns MP; Bahr MJ
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
